ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

ClinicalTrials.gov ID: NCT04278417

Public ClinicalTrials.gov record NCT04278417. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 12:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 96-week, Two-arm, Randomized, Single-masked, Multi-center, Phase III Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

Study identification

NCT ID
NCT04278417
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
689 participants

Conditions and interventions

Interventions

  • Brolucizumab 6 mg Biological
  • Panretinal photocoagulation laser Procedure

Biological · Procedure

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2020
Primary completion
Oct 29, 2023
Completion
Aug 18, 2024
Last update posted
Oct 15, 2025

2020 – 2024

United States locations

U.S. sites
40
U.S. states
16
U.S. cities
35
Facility City State ZIP Site status
Retina Associates SW Tucson Arizona 85704
Retina- Vitreous Assoc Medical Group Beverly Hills California 90211
Retina Consultants of Orange County Fullerton California 92835
Salehi Retina Institute Huntington Beach California 92647
Retina Consultants of Southern California Redlands California 92374
Premiere Practice Management LLC Torrance California 90505
Lundquist Inst BioMed at Harbor Torrance California 90509-2910
Miramar Eye Specialists Ventura California 93003
Advanced Research LLC Deerfield Beach Florida 33064
Rand Eye Institute Deerfield Beach Florida 33064
Pinnacle Research Institute Fort Lauderdale Florida 33309
National Ophthalmic Research Institute Fort Myers Florida 33912-7125
Florida Retina Institute Jacksonville Florida 32216
Blue Oc Clin Res at Palm Bch Eye Ct Lakeland Florida 33801
MedEye Associates Miami Florida 33143
Florida Retina Institute Orlando Florida 32804
Eye Center of North Florida Panama City Florida 32405
Fort Lauderdale Eye Institute Plantation Florida 33324
Retina Associates Elmhurst Illinois 60126
Midwest Eye Institute Indianapolis Indiana 46280
John-Kenyon American Eye Institute PC New Albany Indiana 47150
Retina Associates PA Lenexa Kansas 66215
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
University of Mississippi Med Ctr Jackson Mississippi 39216
Retina Associates Of Cleveland Cleveland Ohio 44122
Dean McGee Eye Institute Oklahoma City Oklahoma 73104
Cascade Medical Research Institute Springfield Oregon 97477
Erie Retinal Surgery Erie Pennsylvania 16507
Charleston Neuroscience Institute Ladson South Carolina 29456
Southeastern Retina Associates P C Knoxville Tennessee 37923
Austin Retina Associates Austin Texas 78705
Texan Eye P A Austin Texas 78731
Retina And Vitreous Of Texas Bellaire Texas 77401
Retina Consultants TX Rsrch Ctr Bellaire Texas 77401
Texas Retina Associates Fort Worth Texas 76104
Valley Retina Institute PA Harlingen Texas 78550
Retina Consultants of Houston PA Houston Texas 77030
Medical Center Opthamology Assoc San Antonio Texas 78240
Retina Associates Of South Texas PA San Antonio Texas 78240
Virginia Eye Consultants Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 80 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04278417, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04278417 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →